A Longitudinal Observational Follow-up of the PRECEPT Study Cohort
NCT ID: NCT00605163
Last Updated: 2008-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
530 participants
OBSERVATIONAL
2006-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing and able to give informed consent
Exclusion Criteria
30 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
H. Lundbeck A/S
INDUSTRY
Parkinson's Disease Foundation
OTHER
United States Department of Defense
FED
The Parkinson Study Group
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Rochester Clinical Trials Coordination Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Barrow Neurological Institute
Phoenix, Arizona, United States
Sun Health Research Institute
Sun City, Arizona, United States
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
The Parkinson's & Movement Disorder Institute
Fountain Valley, California, United States
University of California Irvine
Irvine, California, United States
University of San Diego
La Jolla, California, United States
University of Southern California
Los Angeles, California, United States
Pacific Neuroscience Medical Group
Oxnard, California, United States
University of California Davis
Sacramento, California, United States
The Parkinson's Institute
Sunnyvale, California, United States
University of Colorado Health Sciences Center
Aurora, Colorado, United States
Colorado Neurological Institute
Littleton, Colorado, United States
Institute for Neurogenerative Disorders
New Haven, Connecticut, United States
Mayo Clinic Jacksonville
Jacksonville, Florida, United States
University of South Florida
Tampa, Florida, United States
Cleveland Clinic Florida-Weston
Weston, Florida, United States
Medical College of Georgia
Augusta, Georgia, United States
Northwestern University
Chicago, Illinois, United States
Rush University Medical Center
Chicago, Illinois, United States
University of Chicago
Chicago, Illinois, United States
University of Iowa
Iowa City, Iowa, United States
University of Kansas Medical Center
Kansas City, Kansas, United States
LSU Health Science Center Shreveport
Shreveport, Louisiana, United States
Johns Hopkins University
Baltimore, Maryland, United States
University of Maryland School of Medicine
Baltimore, Maryland, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Boston University
Boston, Massachusetts, United States
Brigham & Women's Hospital
Boston, Massachusetts, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
University of Minnesota
Minneapolis, Minnesota, United States
Creighton University
Omaha, Nebraska, United States
UMDNJ Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States
Albany Medical College
Albany, New York, United States
North Shore-LIJ Health System
Manhasset, New York, United States
Beth Israel Medical Center
New York, New York, United States
Columbia University
New York, New York, United States
University of Rochester
Rochester, New York, United States
Duke University Medical Center
Durham, North Carolina, United States
University of Cincinnati/Cincinnati Children's Hospital
Cincinnati, Ohio, United States
Oregon Health & Science University
Portland, Ohio, United States
Medical University of Ohio
Toledo, Ohio, United States
Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
NeuroHealth Parkinson's Disease Movement Disorders Center
Warwick, Rhode Island, United States
University of Tennessee-Memphis
Memphis, Tennessee, United States
Baylor College of Medicine
Houston, Texas, United States
University of Virginia
Charlottesville, Virginia, United States
University of Calgary
Calgary, Alberta, Canada
University of Alberta
Edmonton, Alberta, Canada
London Health Sciences Centre
London, Ontario, Canada
Ottawa Hospital Civic Site
Ottawa, Ontario, Canada
Toronto Western Hospital, University Health Network
Toronto, Ontario, Canada
University of Sherbrooke
Fleurimont, Quebec, Canada
Hotel-Dieu Hospital-CHUM
Montreal, Quebec, Canada
Saskatoon Disrict Health Board Royal University Hospital
Saskatoon, Saskatchewan, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Parkinson Study Group PRECEPT Investigators. Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease. Neurology. 2007 Oct 9;69(15):1480-90. doi: 10.1212/01.wnl.0000277648.63931.c0. Epub 2007 Sep 19.
Latourelle JC, Beste MT, Hadzi TC, Miller RE, Oppenheim JN, Valko MP, Wuest DM, Church BW, Khalil IG, Hayete B, Venuto CS. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation. Lancet Neurol. 2017 Nov;16(11):908-916. doi: 10.1016/S1474-4422(17)30328-9. Epub 2017 Sep 25.
Related Links
Access external resources that provide additional context or updates about the study.
The Parkinson Study Group (PSG) is a non-profit, cooperative group of Parkinson's disease experts from medical centers in theUnited States and Canada who are dedicated to improving treatment for persons affected by Parkinson's disease.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NINDS 5 U01NS050095-02
Identifier Type: -
Identifier Source: secondary_id
U01NS050095_PostCEPT
Identifier Type: -
Identifier Source: org_study_id